恒瑞医药：累计回购公司股份791.88万股

Core Viewpoint - Heng Rui Medicine announced a share buyback of 7.9188 million shares, representing 0.12% of the company's total share capital, to be completed by October 31, 2025 [1] Group 1 - The company will conduct the share buyback through the Shanghai Stock Exchange's centralized bidding trading system [1] - The buyback is part of the company's strategy to enhance shareholder value [1]